DRKS00013246已完成不适用
6-TGN levels (azathioprine drug monitoring) and markers of mucosal healing in patients with inflammatory bowel disease
MHH OE68100 个研究点目标入组 88 人开始时间: 2017年11月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •IBD, azathioprine Therapy, values for 6-TGN and FC (max. 4 weeks apart), patients from 2009-2016
排除标准
- •Steroids >20 mg, additional immunosuppressive therapy during last 3 months or currently
研究者
相似试验
已完成
4 期
Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum DisorderNMO Spectrum DisorderAzathioprine Adverse ReactionNCT05896605First Affiliated Hospital of Guangxi Medical University63
尚未招募
3 期
Evaluation of the clinical effect of azathioprine lozenge in oral lichen planusLichen planusIRCT20191106045356N10Yazd University of Medical Sciences50
尚未招募
2 期
Improving Tuberculous Meningitis Care: Testing the Safety and Effectiveness of Azathioprine in Managing Paradoxical Reactions - A Patient-Focused StudyCTRI/2023/12/060448Department of Neurology King George Medical University
招募中
4 期
iver toxicity of azathioprine and 6-mercaptopurine in IBD patients.NL-OMON31453Academisch Ziekenhuis Maastricht120
已完成
不适用
Pharmacokinetics of 6-thioguanineISRCTN49579665VU University Medical Centre (VUMC) (The Netherlands)16